Literature DB >> 2720662

Selenium-induced protection against cis-diamminedichloroplatinum(II) nephrotoxicity in mice and rats.

G S Baldew1, C J van den Hamer, G Los, N P Vermeulen, J J de Goeij, J G McVie.   

Abstract

The influence of selenium on cis-diamminedichloroplatinum(II) (c-DDP) nephrotoxicity in mice and rats was assessed, using single doses of both compounds. Sodium selenite, 2 mg of selenium per kg, given 1 h before c-DDP, greatly reduced blood urea nitrogen and creatinine levels and morphological kidney damage in both BALB/c mice and Wistar rats, while administration 1 h after c-DDP did not. Liver toxicity of selenium was evaluated by measuring serum glutamic pyruvate transaminase and serum glutamic oxalate transaminase and by routine histology. No liver damage was observed in animals treated with sodium selenite, 2 mg of selenium per kg, and physiological saline or c-DDP. Pretreatment with sodium selenite did not reduce the antitumor activity of c-DDP against MPC 11 plasmacytoma or Prima breast tumor in BALB/c mice. The present results indicate that sodium selenite may provide protection against c-DDP nephrotoxicity, when it is given before c-DDP. Moreover, selenium has an antineoplastic activity against several tumors. The combination of these qualities may open new perspectives in cancer chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2720662

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Cytotoxic activity of selenosulfate versus selenite in tumor cells depends on cell line and presence of amino acids.

Authors:  Sinikka Hinrichsen; Britta Planer-Friedrich
Journal:  Environ Sci Pollut Res Int       Date:  2016-01-18       Impact factor: 4.223

Review 2.  Selenium for alleviating the side effects of chemotherapy, radiotherapy and surgery in cancer patients.

Authors:  G Dennert; M Horneber
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

3.  Factors affecting human autopsy kidney-cortex and kidney-medulla platinum concentrations after cisplatin administration.

Authors:  D J Stewart; C Dulberg; J M Molepo; N Z Mikhael; V A Montpetit; M D Redmond; R Goel
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

4.  Effect of coadministration of selenite on the toxicity and antitumor activity of cis-diamminedichloroplatinum (II) given repeatedly to mice.

Authors:  M Satoh; A Naganuma; N Imura
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 5.  WR2721 as a modulator of cisplatin- and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach.

Authors:  M Treskes; W J van der Vijgh
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

6.  Effect of bismuth nitrate given in combination with cis-diamminedichloroplatinum(II) on the antitumor activity and renal toxicity of the latter in nude mice inoculated with human bladder tumor.

Authors:  Y Kondo; M Satoh; N Imura; M Akimoto
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 7.  Selenium and lung cancer: a systematic review and meta analysis.

Authors:  Heidi Fritz; Deborah Kennedy; Dean Fergusson; Rochelle Fernandes; Kieran Cooley; Andrew Seely; Stephen Sagar; Raimond Wong; Dugald Seely
Journal:  PLoS One       Date:  2011-11-04       Impact factor: 3.240

8.  Se-methylselenocysteine offers selective protection against toxicity and potentiates the antitumour activity of anticancer drugs in preclinical animal models.

Authors:  S Cao; F A Durrani; K Tóth; Y M Rustum
Journal:  Br J Cancer       Date:  2014-03-11       Impact factor: 7.640

Review 9.  Cisplatin-Induced Nephrotoxicity; Protective Supplements and Gender Differences

Authors:  Mehdi Nematbakhsh; Zahra Pezeshki; Fatemeh Eshraghi Jazi; Bahar Mazaheri; Maryam Moeini; Tahereh Safari; Fariba Azarkish; Fatemeh Moslemi; Maryam Maleki; Alireza Rezaei; Shadan Saberi; Aghdas Dehghani; Maryam Malek; Azam Mansouri; Marzieh Ghasemi; Farzaneh Zeinali; Zohreh Zamani; Mitra Navidi; Sima Jilanchi; Soheyla Shirdavani; Farzaneh Ashrafi
Journal:  Asian Pac J Cancer Prev       Date:  2017-02-01

Review 10.  (Mesenchymal) Stem Cell-Based Therapy in Cisplatin-Induced Acute Kidney Injury Animal Model: Risk of Immunogenicity and Tumorigenicity.

Authors:  Ž Večerić-Haler; A Cerar; M Perše
Journal:  Stem Cells Int       Date:  2017-12-12       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.